title: [Hydration for the prevention of contrast medium-induced nephropathy: an update].
abstract: Contrast medium-induced nephropathy (CIN) continues to be one of the most common causes of hospital-acquired acute renal failure. Since most of the clinical studies on the prophylactic use of different drugs to prevent CIN produced disappointing results, hydration remains the mainstay of prophylaxis. A number of recent prospective randomized trials provided further evidence of the effectiveness of hydration and relevant information regarding the optimization of hydration protocols. It was shown that a bolus hydration solely during examination is not sufficient to prevent CIN. In addition, isotonic 0.9 % saline was superior to the commonly used half-isotonic 0.45 % saline in another trial. An outpatient hydration protocol including oral hydration before the examination followed by forced intravenous hydration over 6 hrs. beginning 30 to 60 min. prior to examination seems to be comparable to the usual hydration over 24 hrs. Another hydration protocol, which could also be very attractive especially for outpatients, included the infusion of sodium bicarbonate. In a recent trial, hydration with sodium bicarbonate, given as a bolus for 1 hr. prior to examination followed by an infusion for 6 hrs. after examination, was more effective than hydration with sodium chloride for the prophylaxis of CIN. However, there is still a lack of large-scale, multi-center trials comparing different hydration protocols and investigating their influence on clinically relevant endpoints such as mortality or the need for dialysis.
authors.affiliation: Radiologisches Institut, Friedrich-Alexander-Universität Erlangen-Nürnberg. Dr.MarcHeinrich@gmx.de
authors.forename: M
authors.initials: M
authors.lastname: Heinrich
authors.forename: M
authors.initials: M
authors.lastname: Uder
mesh_terms: D058186:Acute Kidney Injury / Q000097:blood / Q000139:chemically induced* / Q000517:prevention & control; D000818:Animals; D002986:Clinical Trials as Topic; D003287:Contrast Media / Q000493:pharmacokinetics / Q000633:toxicity*; D005440:Fluid Therapy / Q000379:methods*; D006801:Humans; D008657:Metabolic Clearance Rate / Q000502:physiology; D051381:Rats; D012965:Sodium Chloride / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D003287:Contrast Media; D012965:Sodium Chloride